Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 2 , Pages 134-138 , June 2008

Photodynamic therapy: Off-label and alternative use in dermatological practice

References 

  1. Rossi R, Mori M, Lotti T. Actinic keratosis. Int J Dermatol. 2007;46:895–904
  2. Rossi R, Lotti T, Rashid RM, Liu SW, Alam M. Photodynamic therapy. In: Keyvan Nouri  editors. In skin cancer. McGraw Hill; 2008;p. 549–575
  3. Rossi R, Lotti T, Cappugi P, Sala R, Venturini M, Calzavara-Pinton PG GIDFE. Guidelines for photodynamic therapy in dermatology: treatment protocol. G Ital Dermatol Venereol. 2005;140:637–644
  4. Rossi R, Mavilia L, Ghersetich I, Lotti T. Photodynamic therapy of actinic keratoses with methyl-aminolevulinate (metvix). G Ital Dermatol Venereol. 2005;140(4):381–387
  5. Haddada R, Nesherb E, Weissb J, Skornicka Y, Kashtan H. Photodynamic therapy for Bowen's disease and squamous cell carcinoma of the skin. Photodiagn Photodyn Ther. 2004;1(3):225–230
  6. Sieron A, Kawczyk-Krupka A, Cebula MAW, et al. Photodynamic therapy (PDT) using topically applied δ-aminolevulinic acid (ALA) for the treatment of malignant skin conditions. Photodiagn Photodyn Ther. 2004;1(4):311–317
  7. Allison RR, Sibata CH, Downie GH, Cuenca RE. A clinical review of PDT for cutaneous malignancies. Photodiagn Photodyn Ther. 2006;3(4):214–226
  8. Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol. 2001;45:96–104
  9. Mitra A, Stables GI. Topical photodynamic therapy for non-cancerous skin conditions. Photodiagn Photodyn Ther. 2006;3(2):116–127
  10. Nayeemuddin FA, Wong M, Yell J, et al. Topical photodynamic therapy in disseminated superficial actinic porokeratosis. Clin Exp Dermatol. 2002;27(8):703–706
  11. Forman Taub A. Photodynamic therapy: other uses. Dermatol Clin. 2007;25:101–109
  12. Bissonnette R, Zeng H, McLean DI, et al. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells. Photochem Photobiol. 2001;74(2):339–345
  13. Boehncke WH, Konig K, Kaufmann R, et al. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Arch Dermatol Res. 1994;286(6):300–303
  14. Bissonnette R, Tremblay JF, Juzenas P, et al. Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques. J Invest Dermatol. 2002;119(1):77–83
  15. Robinson DJ, Collins P, Stringer MR, et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Venereol. 1999;79(6):451–455
  16. Fransson J, Ros AM. Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5-aminolaevulinic acid photodynamic therapy. Photodermatol Photoimmunol Photomed. 2005;21(6):326–332
  17. Karrer S, Bosserhoff AK, Weiderer P, et al. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol. 2004;151(4):776–783
  18. Hillemanns P, Untch M, Pröve F, et al. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinc acid. Obstet Gynecol. 1999;93:71–74
  19. Booth S, Poole D, Moghissi K. Initial experience of the use of photodynamic therapy (PDT) in recurrent malignant and pre-malignant lesions of the vulva. Photodiagn Photodyn Ther. 2006;3(3):156–161
  20. Chiu LL, Sun CH, Yeh AT, et al. Photodynamic therapy on keloid fibroblasts in tissue-engineered keratinocyte-fibroblast co-culture. Lasers Surg Med. 2005;37(3):231–244
  21. Bissonnette R, Shapiro J, Zeng H, et al. Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata. Br J Dermatol. 2000;143(5):1032–1035
  22. Svanberg K, Andersson T, Killander D, et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br J Dermatol. 1994;130(6):743–751
  23. Rittenhouse-Diakun K, Van Leengoed H, Morgan J, et al. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA). Photochem Photobiol. 1995;61(5):523–528
  24. Edstrom DW, Porwit A, Ros AM. Photodynamic therapy with topical 5-aminolevulinic acid for Mycosis fungoides: clinical and histological response. Acta Derm Venereol. 2001;81(3):184–188
  25. Mori M, Campolmi P, Mavilia L, Rossi R, Cappugi P, Pimpinelli N. Topical photodynamic therapy for primary cutaneous b-cell lymphoma: a pilot study. J Am Acad Dermatol. 2006;54(3):524–526
  26. Maisch T, Bosl C, Szeimies RM, et al. Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob Agents Chemother. 2005;49(4):1542–1552
  27. Demidova TN, Hamblin MR. Photodynamic therapy targeted to pathogens. Int J Immunopathol Pharmacol. 2004;17(3):245–254
  28. Bisland SK, Chien C, Wilson BC, et al. Pre-clinical in vitro and in vivo studies to examine the potential use of photodynamic therapy in the treatment of osteomyelitis. Photochem Photobiol Sci. 2006;5(1):31–38
  29. O’Riordan K, Akilov OE, Hasan T. The potential for photodynamic therapy in the treatment of localized infections. Photodiagn Photodyn. 2005;2(4):247–262
  30. Teichert MC, Jones JW, Usacheva MN, et al. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(2):155–160
  31. Calzavara-Pinton PG, Venturini M, Capezzera R, et al. Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid. Photodermatol Photoimmunol Photomed. 2004;20(3):144–147
  32. Szeimies RM, Landthaler M, Karrer S. Non-oncologic indications for ALA-PDT. J Dermatolog Treat. 2002;13(Suppl. 1):S13–S18
  33. Gold MH, Boring MM, Bridges TM, et al. The successful use of ALA-PDT in the treatment of recalcitran molluscum contagiosum. J Drugs Dermatol. 2004;3(2):187–190
  34. Smetana Z, Ben-Hur E, Mendelson E, et al. Herpes simplex virus proteins are damaged following photodynamic inactivation with phthalocyanines. J Photochem Photobiol. 1998;B44(1):77–83
  35. Jori G. Photodynamic therapy of microbial infections: state of the art and perspectives. J Environ Pathol Toxicol Oncol. 2006;25(1/2):505–520
  36. Husar K, Skerlev M. Molluscum contagiosum from infancy to maturity. Clin Dermatol. 2002;20:170–172
  37. Ammann R, Hunziker T, Braathen LR. Topical photodynamic therapy in verrucae. Dermatology. 1995;191:346–347
  38. Smetana Z, Malik Z, Orenstein A, et al. Treatment of viral infections with 5-aminolevulinic acid and light. Lasers Surg Med. 1997;21:351–358
  39. Fabbrocini G, Costanzo M, Riccardo A, et al. Photodynamic therapy with topical 5-aminolevulinic acid for the treatment of plantar warts. J Photochem Photobiol B. 2001;61:30–34
  40. Stender IM, Na R, Fogh H, et al. Photodynamic therapy with 5-aminolevulinic acid or placebo for recalcitrant foot and hand warts: randomized doubleblind trial. Clin Exp Dermatol. 1999;24(3):154–159
  41. Ghersetich I, Troiano M, De Giorgi V, Lotti T. receptors and skin ageing and antiageing agents. Dermatol Clin. 2007;25:655–662
  42. Green LJ, McCormick A, Weinstein GD. Photoaging and the skin: the effects of tretinoin. Dermatol Clin. 1993;11:97–105
  43. Rossi R, Troiano M, Lotti T. Terapia fotodinamica per il dermatocosmetologo. In: Lotti T, editor, Il ringiovanimento del volto. UTET; 2006, p. 147–50 [Italian].
  44. Ruiz-Rodriguez R, Sanz-Sanchez T, Cordoba S. Photodynamic photorejuvination. Dermatol Surg. 2002;28(8):742–744

PII: S1572-1000(08)00036-7

doi: 10.1016/j.pdpdt.2008.03.001

Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 2 , Pages 134-138 , June 2008

Article Tools